StocksFin Logo
RYTM logo
$RYTM

Rhythm Pharmaceuticals, Inc.

RYTM country of incorporation
|
https://www.rhythmtx.com
|
Mr. Hunter Smith
|
140 employees
NASDAQ | Healthcare | Biotechnology
RYTM reported its Q322 earnings on November 8, 2022 (103 weeks ago).
$4.28M 316.7% vs. Q321 Revenues Q322
88.4% 12.7% vs. Q321 Gross Profit Margin
-953.8% ! 4.6% vs. Q321 Net Profit Margin
-47.08M ! -16.9% vs. Q321 Free Cash Flow Q322
$-0.79 ! -12.9% vs. Q321 EPS Q322
Company Card Q322
As reported on November 8, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 8, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
4.28M
-52.7%
497k
-40.86M
+9.2%
$-0.79
Q22022
9.07M
+505.2%
378k
-45M
+14.7%
$-0.89
Q12022
1.5M
230k
-52.76M
$-1.05
FY2021
3.15M
 599k
-69.61M
$-1.4
Q42021
1.82M
+76.8%
236k
-42.87M
-22.1%
$-0.85
Q32021
1.03M
+275.2%
222k
-35.11M
+0.8%
$-0.7
Q22021
274k
+682.9%
137k
-35.39M
-180.9%
$-0.7
Q12021
35k
4k
43.75M
$0.92
FY2020
0
 0
-134M
$-3.04
FY2019
0
 0
-140.73M
$-3.86
FY2018
0
 0
-74.06M
$-2.39
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
389.61M
 108.42M
185.09M
2.1M
281.2M
Q22022
277.68M
 82.05M
113.21M
2.26M
195.63M
Q12022
284.82M
 49.06M
78.54M
2.41M
235.77M
FY2021
329.52M
 45.37M
59.25M
1.21M
284.15M
FY2020
187.07M
 20.55M
100.85M
3.62M
166.53M
FY2019
308.52M
 27.5M
62.29M
0
281.02M
FY2018
260.21M
 13.95M
49.54M
0
246.26M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-46.99M
 -39.7M
158.56M
-95k
-47.08M
-9.8%
Q22022
-38.81M
 35.98M
37.5M
-4.06M
-42.87M
+20.3%
Q12022
-53.63M
 72.52M
399k
-127k
-53.76M
FY2021
-146M
 -62.16M
166.48M
-434k
-146.44M
FY2020
-121.98M
 158.53M
2.01M
-214k
-122.19M
FY2019
-122.75M
 -27.97M
163.47M
-3.39M
-126.14M
FY2018
-62.06M
 -87.15M
164.69M
-722k
-62.78M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees